Page 145 - Read Online
P. 145

Page 10 of 13                 Bale et al. Hepatoma Res 2023;9:44  https://dx.doi.org/10.20517/2394-5079.2023.71

               Availability of Data and Materials
               Not applicable.


               Financial Support and Sponsorship
               None.


               Conflicts of Interest
               The authors declared that there are no conflicts of interest.


               Ethical Approval and Consent to Participate
               Not applicable.


               Consent for Publication
               Not applicable.


               Copyright
               © The Author(s) 2023.

               REFERENCES
               1.       Beal EW, Tumin D, Moris D, et al. Cohort contributions to trends in the incidence and mortality of intrahepatic cholangiocarcinoma.
                   Hepatobiliary Surg Nutr 2018;7:270-6.  DOI  PubMed  PMC
               2.       Ma B, Meng H, Tian Y, et al. Distinct clinical and prognostic implication of IDH1/2 mutation and other most frequent mutations in
                   large duct and small duct subtypes of intrahepatic cholangiocarcinoma. BMC Cancer 2020;20:318.  DOI  PubMed  PMC
               3.       Akita M, Fujikura K, Ajiki T, et al. Dichotomy in intrahepatic cholangiocarcinomas based on histologic similarities to hilar
                   cholangiocarcinomas. Mod Pathol 2017;30:986-97.  DOI
               4.       Chapman MH, Thorburn D, Hirschfield GM, et al. British society of gastroenterology and UK-PSC guidelines for the diagnosis and
                   management of primary sclerosing cholangitis. Gut 2019;68:1356-78.  DOI  PubMed  PMC
               5.       Clements O, Eliahoo J, Kim JU, Taylor-Robinson SD, Khan SA. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a
                   systematic review and meta-analysis. J Hepatol 2020;72:95-103.  DOI  PubMed
               6.       European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu, European Association for the Study of
                   the Liver. EASL-ILCA clinical practice guidelines on the management of intrahepatic cholangiocarcinoma. J Hepatol 2023;79:181-
                   208.  DOI  PubMed
               7.       Kim YY, Yeom SK, Shin H, et al. Clinical staging of mass-forming intrahepatic cholangiocarcinoma: computed tomography versus
                   magnetic resonance imaging. Hepatol Commun 2021;5:2009-18.  DOI  PubMed  PMC
               8.       Kim TH, Kim H, Joo I, Lee JM. Combined hepatocellular-cholangiocarcinoma: changes in the 2019 World Health Organization
                   histological classification system and potential impact on imaging-based diagnosis. Korean J Radiol 2020;21:1115-25.  DOI  PubMed
                   PMC
               9.       Malikowski T, Levy MJ, Gleeson FC, et al. Endoscopic ultrasound/fine needle aspiration is effective for lymph node staging in
                   patients with cholangiocarcinoma. Hepatology 2020;72:940-8.  DOI
               10.      Fong ZV, Brownlee SA, Qadan M, Tanabe KK. The clinical management of cholangiocarcinoma in the united states and europe: a
                   comprehensive and evidence-based comparison of guidelines. Ann Surg Oncol 2021;28:2660-74.  DOI  PubMed
               11.      Cholangiocarcinoma Working Group. Italian clinical practice guidelines on cholangiocarcinoma - part ii: treatment. Dig Liver Dis
                   2020;52:1430-42.  DOI  PubMed
               12.      Benson AB, D'Angelica MI, Abbott DE, et al. Hepatobiliary cancers, version 2.2021, NCCN clinical practice guidelines in oncology. J
                   Natl Compr Canc Netw 2021;19:541-65.  DOI  PubMed
               13.      Amini N, Ejaz A, Spolverato G, Kim Y, Herman JM, Pawlik TM. Temporal trends in liver-directed therapy of patients with
                   intrahepatic cholangiocarcinoma in the United States: a population-based analysis. J Surg Oncol 2014;110:163-70.  DOI  PubMed
               14.      Mazzaferro V, Gorgen A, Roayaie S, Droz Dit Busset M, Sapisochin G. Liver resection and transplantation for intrahepatic
                   cholangiocarcinoma. J Hepatol 2020;72:364-77.  DOI  PubMed
               15.      Lamarca A, Ross P, Wasan HS, et al. Advanced intrahepatic cholangiocarcinoma: post Hoc analysis of the ABC-01, -02, and -03
                   clinical trials. J Natl Cancer Inst 2020;112:200-10.  DOI
               16.      Sha M, Jeong S, Xia Q. Analysis of liver resection versus liver transplantation on outcome of small intrahepatic cholangiocarcinoma
                   and combined hepatocellular-cholangiocarcinoma in the setting of cirrhosis. Liver Transpl 2020;26:1202-3.  DOI  PubMed
               17.      Sapisochin G, Facciuto M, Rubbia-Brandt L, et al; iCCA International Consortium. Liver transplantation for "very early" intrahepatic
                   cholangiocarcinoma: International retrospective study supporting a prospective assessment. Hepatology 2016;64:1178-88.  DOI
   140   141   142   143   144   145   146   147   148   149   150